MALACHITE INNOVATIONS LAUNCHES NEW BUSINESS FOCUSED ON MITIGATION BANKING TO RESTORE ENVIRONMENTALLY DEGRADED STREAMS AND WETLANDS
20 déc. 2022 18h48 HE
|
Malachite Innovations, Inc.
CLEVELAND, OHIO, Dec. 20, 2022 (GLOBE NEWSWIRE) -- MALACHITE INNOVATIONS, INC. (OTC Mkts: MLCT) (“Malachite”), a public company focused on improving the health and wellness of people and the planet,...
MALACHITE INNOVATIONS LAUNCHES TERRA PRETA, A NEW BUSINESS FOCUSED ON PRODUCING BIOCHAR FOR AGRICULTURAL AND WATER FILTRATION MARKETS
15 déc. 2022 09h15 HE
|
Malachite Innovations, Inc.
CLEVELAND, OHIO, Dec. 15, 2022 (GLOBE NEWSWIRE) -- MALACHITE INNOVATIONS, INC. (OTC Mkts: MLCT) (“Malachite”), a public company focused on improving the health and wellness of people and the planet,...
MALACHITE INNOVATIONS LAUNCHES NEW BUSINESS FOCUSED ON PROVIDING ECO-FRIENDLY, TECHNOLOGY-DRIVEN SECURITY SERVICES TO ACTIVE AND FORMER MINE SITES USING MILITARY VETERANS AND FIRST RESPONDERS
29 nov. 2022 09h15 HE
|
Malachite Innovations, Inc.
CLEVELAND, OHIO, Nov. 29, 2022 (GLOBE NEWSWIRE) -- MALACHITE INNOVATIONS, INC. (OTC Mkts: MLCT) (“Malachite”), a public company focused on improving the health and wellness of people and the planet,...
MALACHITE INNOVATIONS ANNOUNCES SIGNED LETTER OF INTENT WITH RANGE ENVIRONMENTAL RESOURCES, INC.
15 mars 2022 16h05 HE
|
Malachite Innovations, Inc.
CLEVELAND, OHIO, March 15, 2022 (GLOBE NEWSWIRE) -- MALACHITE INNOVATIONS, INC. (OTC Mkts: MLCT) (“Malachite”) announces that it has entered into a non-binding letter of intent (the “Letter of...
Vitality Biopharma Enters Into $5 Million Equity Line Financing Relationship With Institutional Investor
20 août 2021 09h00 HE
|
Vitality Biopharma, Inc
CLEVELAND, Aug. 20, 2021 (GLOBE NEWSWIRE) -- Vitality Biopharma, Inc. (VBIO) (“Vitality” or the “Company”), an innovation-driven drug development company dedicated to unlocking the therapeutic...
Vitality Biopharma Board Update
27 avr. 2020 16h52 HE
|
Vitality Biopharma, Inc
CLEVELAND, April 27, 2020 (GLOBE NEWSWIRE) -- Vitality Biopharma, Inc. (Ticker: VBIO) (“Vitality Biopharma,” “Vitality,” or the “Company”), a corporation dedicated to the development of cannabinoid...
Vitality Biopharma Welcomes New Executive Management Team
14 mai 2019 09h00 HE
|
Vitality Biopharma, Inc
– Appointment of Current Director Michael Cavanaugh as Interim Chief Executive Officer –– Promotion of Current Controller and Counsel Richard McKilligan to Chief Financial Officer – LOS ANGELES, May ...
Vitality Biopharma Announces Corporate Updates and Completion of an SEC Examination
21 nov. 2018 07h00 HE
|
Vitality Biopharma, Inc
Company appoints two new directors including the Hon. Edward Feighan as new Chairman of the Board LOS ANGELES, Nov. 21, 2018 (GLOBE NEWSWIRE) -- Vitality Biopharma, Inc. (OTCQB: VBIO)...